Company Filing History:
1 out of 8 
1 out of 159 
1 out of 100 Years Active: 2020
Title: Innovations of Jingping Wei in Cancer Treatment
Introduction
Jingping Wei is a notable inventor based in Shanghai, China, recognized for his contributions to the field of biopharmaceuticals. His work primarily focuses on developing innovative treatments for cancer, showcasing his commitment to advancing medical science.
Latest Patents
Jingping Wei holds a patent for an "Anti-c-Met antibody and anti-c-Met antibody-cytotoxic drug conjugate and pharmaceutical use thereof." This invention provides an anti-c-Met antibody or an antigen binding fragment, which can be a chimeric or humanized antibody. The patent also includes pharmaceutical compositions that utilize the humanized anti-c-Met antibody or its fragments, as well as the antibody-cytotoxic drug conjugate, aimed at treating cancer effectively.
Career Highlights
Throughout his career, Jingping Wei has worked with prominent companies in the biopharmaceutical sector. He has been associated with Suzhou Suncadia Biopharmaceuticals Co., Ltd. and Jiangsu Hengrui Medicine Company Ltd., where he has contributed to significant advancements in cancer treatment.
Collaborations
Jingping Wei has collaborated with esteemed colleagues, including Jiajian Liu and Lianshan Zhang, who have played vital roles in his research and development efforts.
Conclusion
Jingping Wei's innovative work in developing anti-c-Met antibodies represents a significant advancement in cancer treatment. His contributions to the field highlight the importance of collaboration and innovation in the pursuit of effective medical solutions.